Donald Castell to Drug Therapy, Combination
This is a "connection" page, showing publications Donald Castell has written about Drug Therapy, Combination.
Connection Strength
0.653
-
Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression. Pharmacotherapy. 2015 Dec; 35(12):1124-9.
Score: 0.113
-
Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough. J Clin Gastroenterol. 2008 Jul; 42(6):676-9.
Score: 0.067
-
Characteristics of symptomatic reflux episodes on Acid suppressive therapy. Am J Gastroenterol. 2008 May; 103(5):1090-6.
Score: 0.067
-
Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest. 2006 Aug; 130(2):386-91.
Score: 0.059
-
Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005 Jun 15; 21(12):1467-74.
Score: 0.055
-
Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy. Dis Esophagus. 2005; 18(6):370-3.
Score: 0.053
-
Nocturnal acid breakthrough: pH, drugs and bugs. Eur J Gastroenterol Hepatol. 2004 May; 16(5):441-3.
Score: 0.051
-
Medical therapy. Management of the refractory patient. Gastroenterol Clin North Am. 1999 Dec; 28(4):847-60.
Score: 0.037
-
A practical approach to heartburn. Hosp Pract (1995). 1999 Nov 15; 34(12):89-94, 97-8.
Score: 0.037
-
Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn. N Engl J Med. 2019 10 17; 381(16):1513-1523.
Score: 0.037
-
Chest pain of undetermined origin. Gastrointest Endosc Clin N Am. 1994 Oct; 4(4):731-46.
Score: 0.026
-
Long-term therapy for chronic gastroesophageal reflux. Arch Intern Med. 1987 Oct; 147(10):1701-2.
Score: 0.016
-
Medical therapy for reflux esophagitis: 1986 and beyond. Ann Intern Med. 1986 Jan; 104(1):112-4.
Score: 0.014
-
Future medical therapy of reflux esophagitis. J Clin Gastroenterol. 1986; 8 Suppl 1:81-5.
Score: 0.014
-
The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines. Arch Intern Med. 1996 Mar 11; 156(5):477-84.
Score: 0.007